Type
. Reproducibility of sensory testing and voluntary muscle testing in evaluating the treatment of acute neuritis in leprosy patients. Leprosy review [Internet]. 1983;54(1):23-30. Available from: http://leprev.ilsl.br/pdfs/1983/v54n1/pdf/v54n1a04.pdf
Type
. Further results on dapsone-resistant leprosy in Bamako (Mali). Leprosy review [Internet]. 1983;54(1):19-21. Available from: http://leprev.ilsl.br/pdfs/1983/v54n1/pdf/v54n1a03.pdf
Type
. [Only a few die of leprosy but 1 billion are at risk of infection]. Lakartidningen. 1983;80(5):336-9.
Type
. Dissociation between allergy and immunity in leprosy. The Practitioner. 1983;227(1376):vii-ix.
Type
. [Thalidomide in dermatology]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 1983;34(2):66-72.
Type
. Leprosy. American family physician. 1983;27(2):25.
Type
. [What causes nerve damage in leprosy?]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke. 1983;103(3):191-2.
Type
. [Polyneuropathy as a form of the primary presentation of leprosy]. Medicina clinica. 1983;80(1):17-9.
Type
. A study of serum fibrinolytic activity in erythema nodosum leprosum (ENL). Leprosy in India. 1983;55(1):95-9.
Type
. Serological study for presence of C-reactive protein, rheumatoid factor, anti streptolysin O in leprosy cases. Leprosy in India. 1983;55(1):86-90.